StonvexLoading…
StonvexStonvexStonvexCore line items from EVGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.85M | $5.58M | $2.98M | $1.68M |
Operating Income | $-14.03M | $-18.80M | $-22.23M | $-26.94M |
Net Income | $-7.83M | $-18.05M | $-25.95M | $-29.84M |
EPS (Diluted) | $1.08 | $-2.90 | $-5.20 | $-6.44 |
Total Assets | $20.05M | $39.86M | $51.10M | $56.13M |
Total Liabilities | $8.07M | $25.03M | $22.42M | Not available |
Cash & Equivalents | $12.96M | $15.30M | $20.77M | $28.98M |
Free Cash Flow OCF − CapEx | $-13.64M | $-20.33M | $-22.15M | $-24.85M |
Shares Outstanding | 8.72M | 6.51M | 5.08M | 41.26M |